Subtopic Deep Dive

Genetic Risk Factors in Autoimmune Liver Diseases
Research Guide

What is Genetic Risk Factors in Autoimmune Liver Diseases?

Genetic risk factors in autoimmune liver diseases are specific genomic loci, primarily identified through genome-wide association studies (GWAS), that confer susceptibility to conditions such as autoimmune hepatitis type 1 (AIH-1), primary biliary cholangitis (PBC), and primary sclerosing cholangitis (PSC).

GWAS have pinpointed HLA and non-HLA risk loci across these diseases, with studies reporting nine new PSC loci (Liu et al., 2013, 389 citations) and novel AIH-1 variants (de Boer et al., 2014, 297 citations). Meta-analyses identified additional PBC risk loci and pathways (Cordell et al., 2015, 303 citations). Over 10 key papers from 2012-2017, with 200-1359 citations each, form the core literature.

15
Curated Papers
3
Key Challenges

Why It Matters

Genetic risk loci enable polygenic risk scores for early risk stratification in PBC, PSC, and AIH-1, guiding personalized screening and intervention before liver failure (Ji et al., 2016; Cordell et al., 2015). These discoveries highlight immune pathways like HLA associations, informing targeted therapies amid limited immunomodulatory options (Hirschfield et al., 2017). In PSC, new loci quantify IBD overlap, aiding multidisciplinary management (Liu et al., 2013; Ji et al., 2016).

Key Research Challenges

Functional Validation of Loci

Linking GWAS-identified variants to causal genes and mechanisms remains difficult due to linkage disequilibrium and liver-specific expression. Studies like Folseraas et al. (2012, 233 citations) detected novel PSC loci but lack functional follow-up. Validation requires integrative epigenomics and CRISPR models.

Polygenic Risk Score Accuracy

Developing transferable polygenic risk scores across ancestries faces limited non-European data. Ji et al. (2016, 370 citations) quantified PSC-IBD genetics but scores underperform in diverse cohorts. Harmonizing HLA/non-HLA effects is key.

HLA Fine-Mapping Resolution

Dense HLA genotyping struggles with high polymorphism, obscuring causal alleles in AIH-1 and PBC. de Boer et al. (2014, 297 citations) identified AIH-1 variants near HLA but fine-mapping lags. Advanced imputation and sequencing are needed.

Essential Papers

1.

EASL Clinical Practice Guidelines: The diagnosis and management of patients with primary biliary cholangitis

Gideon M. Hirschfield, Ulrich Beuers, Christophe Corpechot et al. · 2017 · Journal of Hepatology · 1.4K citations

2.

The First European Evidence-based Consensus on Extra-intestinal Manifestations in Inflammatory Bowel Disease

Marcus Harbord, Vito Annese, Stephan R. Vavricka et al. · 2015 · Journal of Crohn s and Colitis · 786 citations

This is the first European Crohn’s and Colitis Organisation [ECCO] consensus guideline that addresses extra-intestinal manifestations [EIMs] in inflammatory bowel disease [IBD]. It has been drafted...

3.

Dense genotyping of immune-related disease regions identifies nine new risk loci for primary sclerosing cholangitis

Jimmy Z. Liu, Johannes R. Hov, Trine Folseraas et al. · 2013 · Nature Genetics · 389 citations

5.

International genome-wide meta-analysis identifies new primary biliary cirrhosis risk loci and targetable pathogenic pathways

Heather J. Cordell, Younghun Han, George Mells et al. · 2015 · Nature Communications · 303 citations

Abstract Primary biliary cirrhosis (PBC) is a classical autoimmune liver disease for which effective immunomodulatory therapy is lacking. Here we perform meta-analyses of discovery data sets from g...

6.

Genome-Wide Association Study Identifies Variants Associated With Autoimmune Hepatitis Type 1

Ynto S. de Boer, Nicole M. F. van Gerven, Antonie Zwiers et al. · 2014 · Gastroenterology · 297 citations

7.

Autoimmune liver disease, autoimmunity and liver transplantation

Marco Carbone, James Neuberger · 2013 · Journal of Hepatology · 239 citations

Reading Guide

Foundational Papers

Start with Liu et al. (2013, 389 citations) for PSC loci genotyping and de Boer et al. (2014, 297 citations) for AIH-1 variants to grasp core GWAS approaches before Folseraas et al. (2012, 233 citations) extended analysis.

Recent Advances

Study Ji et al. (2016, 370 citations) for PSC-IBD genetics and Cordell et al. (2015, 303 citations) for PBC pathways to see meta-analytic advances.

Core Methods

Genome-wide association studies with dense immune-region genotyping, HLA imputation, polygenic risk modeling, and IBD overlap heritability estimation.

How PapersFlow Helps You Research Genetic Risk Factors in Autoimmune Liver Diseases

Discover & Search

Research Agent uses searchPapers and exaSearch to retrieve GWAS on PSC/AIH-1/PBC, then citationGraph maps connections from Liu et al. (2013, 389 citations) to related loci papers. findSimilarPapers expands to non-HLA risks from Cordell et al. (2015).

Analyze & Verify

Analysis Agent applies readPaperContent to extract risk loci from Ji et al. (2016), verifies overlap statistics via verifyResponse (CoVe) and runPythonAnalysis for odds ratio meta-analysis with GRADE grading of evidence strength in HLA associations.

Synthesize & Write

Synthesis Agent detects gaps in functional validation post-GWAS (e.g., Liu et al., 2013), flags contradictions in PSC-IBD links; Writing Agent uses latexEditText, latexSyncCitations for risk score manuscripts, latexCompile for figures, exportMermaid for locus networks.

Use Cases

"Compute polygenic risk score overlap between PSC GWAS from Liu 2013 and Ji 2016."

Research Agent → searchPapers + citationGraph → Analysis Agent → runPythonAnalysis (pandas odds ratio merge, matplotlib plot) → researcher gets CSV of combined risk loci with statistical p-values.

"Draft LaTeX review of HLA loci in AIH-1 from de Boer 2014."

Research Agent → findSimilarPapers → Synthesis Agent → gap detection → Writing Agent → latexEditText + latexSyncCitations + latexCompile → researcher gets compiled PDF with cited GWAS tables.

"Find code for PSC genetic analysis from Folseraas 2012 paper."

Research Agent → paperExtractUrls → Code Discovery → paperFindGithubRepo + githubRepoInspect → researcher gets validated GitHub scripts for locus imputation with README usage.

Automated Workflows

Deep Research workflow conducts systematic review of 50+ GWAS papers on PBC/PSC/AIH-1 loci via searchPapers → citationGraph → structured report with GRADE scores. DeepScan applies 7-step analysis with CoVe checkpoints to validate Liu et al. (2013) loci against recent meta-analyses. Theorizer generates hypotheses on non-HLA pathway convergence from Cordell et al. (2015) and Ji et al. (2016).

Frequently Asked Questions

What defines genetic risk factors in autoimmune liver diseases?

They are GWAS-identified HLA and non-HLA loci increasing susceptibility to AIH-1, PBC, and PSC, such as nine PSC loci in Liu et al. (2013).

What are key methods used?

Dense genotyping of immune regions (Liu et al., 2013), international meta-GWAS (Cordell et al., 2015), and IBD overlap quantification (Ji et al., 2016).

What are major papers?

Liu et al. (2013, 389 citations) on PSC loci; de Boer et al. (2014, 297 citations) on AIH-1 variants; Cordell et al. (2015, 303 citations) on PBC meta-analysis.

What open problems exist?

Functional validation of loci, ancestry-diverse polygenic scores, and HLA fine-mapping resolution lack progress beyond initial GWAS.

Research Liver Diseases and Immunity with AI

PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:

See how researchers in Health & Medicine use PapersFlow

Field-specific workflows, example queries, and use cases.

Health & Medicine Guide

Start Researching Genetic Risk Factors in Autoimmune Liver Diseases with AI

Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.

See how PapersFlow works for Medicine researchers